If
you’re one of the estimated 54 million Americans suffering from osteoporosis
(a condition that weakens bone density), you’ll want to know about new
guidelines just issued on some of the most widely prescribed medications.
The
journal Annals of Internal Medicine
recently published an update on the American
College of Physicians’ widely followed recommendations from 2008,
specifically addressing the previous belief that certain types of osteoporosis medications
carry harmful risks including atrial fibrillation and additional joint pain.
Research
now shows the risks are minimal and that taking these medications to protect
bones over the long-term are extremely beneficial. As the typical age of
someone suffering from osteoporosis is over 50 years, and as your risk for a
traumatic fall, ending in broken bones, fractures,
and even death, increases as you get older, strong bones are essential.
The new advisory
suggests doctors continue to prescribe bisphosphonates or denosumab medications
for at least five years following an initial diagnosis, especially for women. (Many
patients tend to go off their medications after a short while if they haven’t
experienced a recent injury.)
Bisphosphonates help
decrease the resorption, or breakdown, of older bones. Common brands of
bisphosphonates include Fosomax, Reclast, and Zometa
Denosumab drugs are
engineered antibodies designed to combat the onset and early effects of
osteoporosis, prescribed under the Prolia and Xgeva brands.
In
addition, the advisory panel suggested avoiding estrogen replacement therapy
for women in favor of other treatments that offer greater bone health benefits
and less unpleasant side effects.
To help alleviate your
symptoms of osteoporosis, we recommend taking your medications as prescribed by
your orthopedist, and also adopting a diet rich in calcium and Vitamin D. Use
supplements as directed, and exercise regularly to keep muscles and joints in good
shape.
If you have questions
about your osteoporosis medication, or would like to schedule a bone density exam with one of our specialists, please contact us for an appointment.
(Adapted
from CNN-Health)
Keep up with Texas Orthopedics news by following us on Facebook and Twitter (@TexasOrthopedic).
No comments:
Post a Comment